表紙
市場調査レポート

抜毛症:世界の治験レビュー

Trichotillomania Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 310345
出版日 ページ情報 英文 51 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.51円で換算しております。
Back to Top
抜毛症:世界の治験レビュー Trichotillomania Global Clinical Trials Review, H2, 2014
出版日: 2014年08月12日 ページ情報: 英文 51 Pages
概要

当レポートでは、抜毛症に関する臨床研究の最新動向について分析し、疾患治療法の概要や、治験における主要国、G7諸国およびE7(新興7カ国)における治験数および被験者採用の状況、フェーズ(相)段階別の進行状況、有望なスポンサー、各企業研究機関での研究の進行状況、有望な薬剤の比較といった情報をまとめてお届けします。

目次

イントロダクション

  • 抜毛症
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • 北米の主要国における治験件数
    • 中東およびアフリカにおける治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:中枢神経系の治験件数に対する抜毛症の治験件数比率

G7諸国での治験件数:フェーズ(相)別

G7諸国での治験件数:進捗状況別

E7諸国(新興7ヶ国)での治験件数:中枢神経系の治験件数に対する抜毛症の治験件数比率

フェーズ(相)別の治験件数

  • 進行中の治験:フェーズ(相)別

進捗状況別の治験件数

エンドポイント達成状況別の治験件数

一定期間に採用された被験者

スポンサーの種類別治験件数

有望な薬剤

治験のプロファイル

  • 代表的な研究機関病院の治験の概要
    • National Institute of Mental Health
    • Massachusetts General Hospital
    • University of Chicago
    • American University of Beirut Medical Center
    • Yale University
    • University of South Florida
    • University of Sao Paulo
    • Hamilton Health Sciences
    • University of Pennsylvania
    • Stanford University

5つの代表的な治験のプロファイル

付録

図表一覧

目次

GlobalData's clinical trial report, "Trichotillomania Global Clinical Trials Review, H2, 2014" provides data on the Trichotillomania clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Trichotillomania. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Trichotillomania. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Trichotillomania
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Trichotillomania to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Trichotillomania to Central Nervous System Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Drugs
    • Clinical Trial Overview of Top Institutes / Government
      • National Institute of Mental Health
      • Clinical Trial Overview of National Institute of Mental Health
      • Massachusetts General Hospital
      • Clinical Trial Overview of Massachusetts General Hospital
      • University of Chicago
      • Clinical Trial Overview of University of Chicago
      • American University of Beirut Medical Center
      • Clinical Trial Overview of American University of Beirut Medical Center
      • Yale University
      • Clinical Trial Overview of Yale University
      • University of South Florida
      • Clinical Trial Overview of University of South Florida
      • University of Sao Paulo
      • Clinical Trial Overview of University of Sao Paulo
      • Hamilton Health Sciences
      • Clinical Trial Overview of Hamilton Health Sciences
      • University of Pennsylvania
      • Clinical Trial Overview of University of Pennsylvania
      • Stanford University
      • Clinical Trial Overview of Stanford University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Trichotillomania Therapeutics, Global, Clinical Trials by Region, 2014*
  • Trichotillomania Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Trichotillomania Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Trichotillomania Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Trichotillomania Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Trichotillomania Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Trichotillomania to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Trichotillomania Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Trichotillomania Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Trichotillomania to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Trichotillomania Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Trichotillomania Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Trichotillomania Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Trichotillomania Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Trichotillomania Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Trichotillomania Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Trichotillomania Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Trichotillomania Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2014*
  • Trichotillomania Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014*
  • Trichotillomania Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Chicago, 2014*
  • Trichotillomania Therapeutics Clinical Trials Market, Global, Clinical Trials by American University of Beirut Medical Center, 2014*
  • Trichotillomania Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2014*
  • Trichotillomania Therapeutics Clinical Trials Market, Global, Clinical Trials by University of South Florida, 2014*
  • Trichotillomania Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2014*
  • Trichotillomania Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamilton Health Sciences, 2014*
  • Trichotillomania Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2014*
  • Trichotillomania Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014*

List of Figures

  • Trichotillomania Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Trichotillomania Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Trichotillomania Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Trichotillomania to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Trichotillomania Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Trichotillomania Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Trichotillomania to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Trichotillomania Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Trichotillomania Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Trichotillomania Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Trichotillomania Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Trichotillomania Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Trichotillomania Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • GlobalData Methodology
Back to Top